Investigational Assay for Haplotype Phasing of the Huntingtin Gene

Novel treatments for Huntington’s disease (HD), a progressive neurodegenerative disorder, include selective targeting of the mutant allele of the huntingtin gene (mHTT) carrying the abnormally expanded disease-causing cytosine-adenine-guanine (CAG) repeat. WVE-120101 and WVE-120102 are investigation...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Ther Methods Clin Dev
Main Authors: Svrzikapa, Nenad, Longo, Kenneth A., Prasad, Nripesh, Boyanapalli, Ramakrishna, Brown, Jeffrey M., Dorset, Daniel, Yourstone, Scott, Powers, Jason, Levy, Shawn E., Morris, Aaron J., Vargeese, Chandra, Goyal, Jaya
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Gene & Cell Therapy 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648085/
https://ncbi.nlm.nih.gov/pubmed/33209959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.09.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares